Exponent, Inc. (EXPO) Expected to Announce Quarterly Sales of $91.14 Million

Wall Street brokerages forecast that Exponent, Inc. (NASDAQ:EXPO) will post $91.14 million in sales for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Exponent’s earnings. The lowest sales estimate is $91.10 million and the highest is $91.18 million. Exponent posted sales of $90.68 million during the same quarter last year, which suggests a positive year over year growth rate of 0.5%. The firm is scheduled to issue its next earnings results on Thursday, April 18th.

According to Zacks, analysts expect that Exponent will report full-year sales of $380.36 million for the current year, with estimates ranging from $377.90 million to $382.81 million. For the next financial year, analysts anticipate that the firm will report sales of $405.81 million, with estimates ranging from $403.90 million to $407.71 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for Exponent.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, January 31st. The business services provider reported $0.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.29 by $0.01. Exponent had a net margin of 19.04% and a return on equity of 21.53%. The business had revenue of $85.27 million for the quarter, compared to the consensus estimate of $88.21 million.

A number of analysts have recently commented on EXPO shares. BidaskClub cut shares of Exponent from a “strong-buy” rating to a “buy” rating in a report on Friday, November 30th. ValuEngine upgraded shares of Exponent from a “sell” rating to a “hold” rating in a report on Thursday, December 13th. Finally, Zacks Investment Research cut shares of Exponent from a “buy” rating to a “hold” rating in a report on Tuesday, February 5th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $56.00.

Shares of EXPO stock opened at $52.52 on Tuesday. Exponent has a 12 month low of $35.63 and a 12 month high of $54.58. The firm has a market cap of $2.69 billion, a PE ratio of 42.02 and a beta of 0.40.

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 22nd. Stockholders of record on Friday, March 8th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date is Thursday, March 7th. This is a boost from Exponent’s previous quarterly dividend of $0.13. Exponent’s payout ratio is 41.60%.

Several hedge funds have recently made changes to their positions in the company. BlackRock Inc. boosted its holdings in shares of Exponent by 0.3% during the 4th quarter. BlackRock Inc. now owns 7,502,036 shares of the business services provider’s stock valued at $380,427,000 after buying an additional 20,319 shares in the last quarter. Vanguard Group Inc. boosted its stake in Exponent by 2.8% in the 3rd quarter. Vanguard Group Inc. now owns 5,147,145 shares of the business services provider’s stock worth $275,887,000 after purchasing an additional 139,183 shares in the last quarter. Vanguard Group Inc boosted its stake in Exponent by 2.8% in the 3rd quarter. Vanguard Group Inc now owns 5,147,145 shares of the business services provider’s stock worth $275,887,000 after purchasing an additional 139,183 shares in the last quarter. Conestoga Capital Advisors LLC boosted its stake in Exponent by 2.6% in the 4th quarter. Conestoga Capital Advisors LLC now owns 2,310,721 shares of the business services provider’s stock worth $117,177,000 after purchasing an additional 57,955 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in Exponent by 103.3% in the 2nd quarter. Northern Trust Corp now owns 920,197 shares of the business services provider’s stock worth $44,447,000 after purchasing an additional 467,647 shares in the last quarter. Hedge funds and other institutional investors own 89.92% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Read More: Are 12b-1 Fees Affecting Your Mutual Fund Performance?

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply